Top
FIGN has not been detected as a mutational cancer driver

FIGN
Ensembl id ENSG00000182263
Mutated samples
Coding Sequence 80 (1.2%)
Protein Affecting 58 (0.9%)
Mode of action Unclassified
Known driver No
Cancer type Signals (Biases)
Clust Clustered Mutations FM Functional Mutations Rec Recurrent Mutations
This plot shows the most recurrently mutated cancer types in all FIGN gene mutations. Each bar of the histogram indicates the amount of samples with PAMs.

Cancer type Driver Mutated samples (CS) Mutated samples (PAM) % Mutated samples (PAM)
Head and neck squamous cell carcinoma No 10 10 2.67
Lung squamous cell carcinoma No 12 9 5.17
Colorectal adenocarcinoma No 6 6 2.62
Lung adenocarcinoma No 6 5 1.28
Breast carcinoma No 5 5 0.44
Bladder carcinoma No 3 3 3.06
Uterine corpus endometrioid carcinoma No 4 3 1.30
Stomach adenocarcinoma No 3 3 1.86
Esophageal carcinoma No 5 3 2.05
Prostate adenocarcinoma No 2 2 0.82
Renal clear cell carcinoma No 3 2 0.48
Cutaneous melanoma No 5 2 0.54
Hepatocarcinoma No 3 1 1.11
Chronic lymphocytic leukemia No 5 1 0.34
Serous ovarian adenocarcinoma No 1 1 0.32
Small cell lung carcinoma No 2 1 1.45
Glioblastoma multiforme No 2 1 0.26
Diffuse B cell lymphoma No 3 0 0.00
The mutations needle plot shows the distribution of the observed cancer mutations along the protein sequence and it's possible mutational clusters and hotspots. The needles' height and head size represent mutational recurrence. Needles of different categories that fall in the same amino acid residues are stacked.

Variant Locus Samples AA pos AA change Consequence